45 results on '"Gossiel, Fatma"'
Search Results
2. Changes in Collagen Type I C-Telopeptide and Procollagen Type I N-Terminal Propeptide During the Menopause Transition
3. Effect of age and gender on serum growth differentiation factor 15 and its relationship to bone density and bone turnover
4. 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial
5. Bone Turnover Markers: Basic Biology to Clinical Applications
6. The association in men and women between Growth Differentiation Factor 15, bone density and bone turnover
7. Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial
8. Development of the Bone Phenotype and microRNA Profile in Adults With Low‐Density Lipoprotein Receptor‐Related Protein 5–High Bone Mass ( LRP5‐HBM) Disease
9. Vitamin D levels in type 1 diabetes with and without neuropathy; A case-control study
10. Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic
11. Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease
12. Long-Term Selenium-Yeast Supplementation Does Not Affect Bone Turnover Markers: A Randomized Placebo-Controlled Trial
13. The relationship between bone regulatory markers and bone turnover in renal osteodystrophy
14. The effect of denosumab treatment on osteoclast precursor cells in postmenopausal osteoporosis
15. P0885THE RELATIONSHIP BETWEEN BONE REGULATORY MARKERS AND BONE TURNOVER IN RENAL OSTEODYSTROPHY
16. Short term mechanical stimulation using whole body vibration identifies differences in bone response between prepubertal boys with and without prior fracture
17. Response to mechanical stimulation of bone in children with osteogenesis imperfecta and the effect of bisphosphonate therapy
18. Losartan reduces circulating TGFb and CTX and increases vertebral bone mass in the OIM mouse
19. O29 Bone turnover in pregnancy, measured by urinary C-terminal telopeptide of type I collagen (CTX), is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the MAVIDOS trial
20. Effect of vitamin D supplementation on free and total vitamin D: A comparison of Asians and Caucasians
21. Bone turnover markers after the menopause: T-score approach
22. Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy
23. Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial
24. Effect of Teriparatide Treatment on Circulating Periostin and Its Relationship to Regulators of Bone Formation and BMD in Postmenopausal Women With Osteoporosis
25. DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful?
26. Bone Turnover Markers: Use in Fracture Prediction
27. Effect of age and gender on serum periostin: Relationship to cortical measures, bone turnover and hormones
28. Cortical-Bone Fragility — Insights from sFRP4 Deficiency in Pyle’s Disease
29. The response of fibroblast growth factor-23 to teriparatide in postmenopausal osteoporosis
30. Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnover
31. Diagnostic Accuracy of Bone Turnover Markers as a Screening Tool for Aseptic Loosening after Total Hip Arthroplasty
32. Normocalcaemic hypoparathyroidism: prevalence and effect on bone status in older women. The OPUS study
33. Type I collagen degradation during tissue repair: Comparison of mechanisms following fracture and acute coronary syndromes
34. Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial
35. Establishing reference intervals for bone turnover markers in healthy postmenopausal women in a nonfasting state
36. The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal women with rsteoporosis: The TRIO study
37. Vitamin D is low in obesity, and this is due to greater volume of distribution
38. The effect of bisphosphonate treatment on sclerostin levels in postmenopausal osteoporosis: the TRIO study
39. Determinants of bone turnover marker response to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study
40. Oxytocin, a New Determinant of Bone Mineral Density in Post-Menopausal Women: Analysis of the OPUS Cohort
41. Effects of Src kinase inhibition by saracatinib (AZD0530) on bone turnover in advanced malignancy in a Phase I study
42. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5
43. Use of anin VitroModel of Tissue-Engineered Skin to Investigate the Mechanism of Skin Graft Contraction
44. Use of anin VitroModel of Tissue-Engineered Skin to Investigate the Mechanism of Skin Graft Contraction
45. Serum Retinoids and β‐Carotene as Predictors of Hip and Other Fractures in Elderly Women
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.